BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 23137841)

  • 21. Protein and antigenic variability among Mycoplasma hyopneumoniae strains by SDS-PAGE and immunoblot.
    Assunção P; De la Fe C; Ramírez AS; González Llamazares O; Poveda JB
    Vet Res Commun; 2005 Oct; 29(7):563-74. PubMed ID: 16142605
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral immunization of swine with attenuated Salmonella typhimurium aroA SL3261 expressing a recombinant antigen of Mycoplasma hyopneumoniae (NrdF) primes the immune system for a NrdF specific secretory IgA response in the lungs.
    Fagan PK; Walker MJ; Chin J; Eamens GJ; Djordjevic SP
    Microb Pathog; 2001 Feb; 30(2):101-10. PubMed ID: 11162190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure of P46, an immunodominant surface protein from Mycoplasma hyopneumoniae: interaction with a monoclonal antibody.
    Guasch A; Montané J; Moros A; Piñol J; Sitjà M; González-González L; Fita I
    Acta Crystallogr D Struct Biol; 2020 May; 76(Pt 5):418-427. PubMed ID: 32355038
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protective immune responses in mice induced by intramuscular and intranasal immunization with a Mycoplasma pneumoniae P1C DNA vaccine.
    Zhu C; Wu Y; Chen S; Yu M; Zeng Y; You X; Xiao J; Wang S
    Can J Microbiol; 2012 May; 58(5):644-52. PubMed ID: 22540220
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Recombinant Chimera Vaccine Composed of LTB and
    Liu W; Jiang P; Song T; Yang K; Yuan F; Gao T; Liu Z; Li C; Guo R; Xiao S; Tian Y; Zhou D
    Vaccines (Basel); 2023 Jul; 11(8):. PubMed ID: 37631860
    [No Abstract]   [Full Text] [Related]  

  • 26. Protective effect of a DNA vaccine delivered in attenuated Salmonella typhimurium against Toxoplasma gondii infection in mice.
    Qu D; Wang S; Cai W; Du A
    Vaccine; 2008 Aug; 26(35):4541-8. PubMed ID: 18590785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined vaccine regimen based on parenteral priming with a DNA vaccine and administration of an oral booster consisting of a recombinant Salmonella enterica serovar Typhimurium vaccine strain for immunization against infection with human-derived enterotoxigenic Escherichia coli strains.
    Lásaro MO; Luiz WB; Sbrogio-Almeida ME; Nishimura LS; Guth BE; Ferreira LC
    Infect Immun; 2004 Nov; 72(11):6480-91. PubMed ID: 15501779
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Construction and immunogenicity of DNA vaccines encoding fusion protein of murine complement C3d-p28 and GP5 gene of porcine reproductive and respiratory syndrome virus.
    Zhang D; Xia Q; Wu J; Liu D; Wang X; Niu Z
    Vaccine; 2011 Jan; 29(4):629-35. PubMed ID: 21134449
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative efficacy of commercial Mycoplasma hyopneumoniae and porcine circovirus 2 (PCV2) vaccines in pigs experimentally infected with M. hyopneumoniae and PCV2.
    Kim D; Kim CH; Han K; Seo HW; Oh Y; Park C; Kang I; Chae C
    Vaccine; 2011 Apr; 29(17):3206-12. PubMed ID: 21354247
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene conjugation of molecular adjuvant C3d3 to hCGbeta increased the anti-hCGbeta Th2 and humoral immune response in DNA immunization.
    Wang XL; Zhao XR; Yu M; Yuan MM; Yao XY; Li DJ
    J Gene Med; 2006 Apr; 8(4):498-505. PubMed ID: 16389614
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunoenhancement of Recombinant Neisseria meningitides PorB Protein on Porcine Circovirus Type 2 and Mycoplasma hyopneumoniae Genetically Engineered Vaccines.
    Yang R; Tao Y; Li G; Chen J; Shu J; He Y
    Protein Pept Lett; 2019; 26(10):776-784. PubMed ID: 31208304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel DNA vaccine for protective immunity against virulent Mycobacterium bovis in mice.
    Liu S; Gong Q; Wang C; Liu H; Wang Y; Guo S; Wang W; Liu J; Shao M; Chi L; Zhao K; Wang Z; Shi Y; Huang Y; Guli A; Zhang C; Kong X
    Immunol Lett; 2008 May; 117(2):136-45. PubMed ID: 18339431
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of a highly immunogenic Mycoplasma hyopneumoniae lipoprotein Mhp366 identified by peptide-spot array.
    Meens J; Bolotin V; Frank R; Böhmer J; Gerlach GF
    Vet Microbiol; 2010 May; 142(3-4):293-302. PubMed ID: 19913364
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of combined porcine reproductive and respiratory syndrome virus and Mycoplasma hyopneumoniae vaccination in piglets.
    Drexler CS; Witvliet MH; Raes M; van de Laar M; Eggen AA; Thacker EL
    Vet Rec; 2010 Jan; 166(3):70-4. PubMed ID: 20081177
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improved cellular immune response elicited by a ubiquitin-fused ESAT-6 DNA vaccine against Mycobacterium tuberculosis.
    Wang QM; Kang L; Wang XH
    Microbiol Immunol; 2009 Jul; 53(7):384-90. PubMed ID: 19563397
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DNA vaccine constructs expressing Mycobacterium tuberculosis-specific genes induce immune responses.
    Hanif SN; Al-Attiyah R; Mustafa AS
    Scand J Immunol; 2010 Nov; 72(5):408-15. PubMed ID: 21039735
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Production and characterization of recombinant transmembrane proteins from Mycoplasma hyopneumoniae.
    Marchioro SB; Simionatto S; Galli V; Conceição FR; Brum CB; Fisch A; Gomes CK; Dellagostin OA
    Vet Microbiol; 2012 Feb; 155(1):44-52. PubMed ID: 21890287
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficient site-directed mutagenesis using an overlap extension-PCR method for expressing Mycoplasma hyopneumoniae genes in Escherichia coli.
    Simionatto S; Marchioro SB; Galli V; Luerce TD; Hartwig DD; Moreira AN; Dellagostin OA
    J Microbiol Methods; 2009 Oct; 79(1):101-5. PubMed ID: 19733599
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mycoplasma hyopneumoniae and Mycoplasma flocculare differential domains from orthologous surface proteins induce distinct cellular immune responses in mice.
    Leal FMDA; Virginio VG; Martello CL; Paes JA; Borges TJ; Jaeger N; Bonorino C; Ferreira HB
    Vet Microbiol; 2016 Jul; 190():50-57. PubMed ID: 27283856
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of immune responses induced in mice by vaccination with DNA vaccine constructs expressing mycobacterial antigen 85A and interleukin-21 and Bacillus Galmette-Guérin.
    Dou J; Tang Q; Zhao F; Chu L; Chen J; Cao M; Liu C; Wang Y; Li Y; Li JL
    Immunol Invest; 2008; 37(2):113-27. PubMed ID: 18300037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.